>PROKKA_00001 Clostridium P-47 protein
MNNLKPFIYYDWQKTILKNTKENYSINEIIPKTFFMELHGTKITNSTLNGTWKAWNLTDE
GEGSHPVLKCIIDDGYLDMNFGASSEKISLKNVWIKLCMKINPNSDGTYSIPEKSSSFYI
KDNSLKISKDNLILDKYLNKLMLSYFKNNIKNIEMFINKSRIQTKVVGDLSLLGWNTENS
VSFRTMNEFIKKDNLYPKDFKAVYSYRKMTFTATGTFDSWKMTTGADGRNIRFKCPIKSA
TYDLDGDVFNSSTENFLLIQVDLTYFDSKTTINDPTGENDGKQFNLKIKTNDDKLKNVLI
VDYNLTDTDGSMISEDKDFLSLAFRNWFNENIQQFEQIFAYILLDETAKIPEYQWLKPTQ
ISYGSTSVETANDEPDLDASIFSAMSMVENNTNSTPSHAVDNRMLQLTKTQAAFGISFPL
FIEHFLKQALLSSQFISVDDIVADINTLTITNNKQIIFGKVENSDGKNVDSSLKPGKLKL
SLQNNLIVLELFDLTWEQGRGVTGHFDFRQEYELALESKSGKQIPILKVHDEPEIEYYVE
EAQWKTNENMIVSAVVGTVFSMILGAGIKLAGSALSKAGKLIRSKATTIKGRKKIYINRS
NVRQLRKDSGVTEIELQRINRRNSSIAAEDARLISNNGTTSIQTLGDMKKKPMSTGQRIA
IGAKKIAGTALMFGAVSLGMNFGEMLINYINAMENNDYNAIPGINSFMQQCIGAMQWPDK
DSELKVTFGKLQGIYLLGGTLEKNNKPNSK*
>PROKKA_00002 hypothetical protein
MKQTFSFNFDDTLSNSSGLIHLEKVNQNCSPNYQYFKIKFIEGYLHIKNKSGDILEKYDL
KDLISLIALKKDYLKLSSPNNKKPKDFTNIKNKHLENKFNLYIINEDINGKITKNGFLEE
IILNRLLLSILLGNEENLLQIA*
>PROKKA_00003 RNA polymerase factor sigma-70
MEDLFFIIKILKDDNKKFEDIYTNYKNLIDIFIKKYNLSENYNDILNHFWIILKKADLNK
FNTENDLNKYISKCLKRYCLSICMKKNRDKKIIYNSEITNINLNLIQDNCFNDIEFEFKD
LISILPNTQKNIIYMKFFKDMKDIQIAKKLKISRQSVYKNKNLALEKLKPILKELINI*
>PROKKA_00004 Clostridium P-47 protein
MNTYGWDIVYGCSKRVVNKHLKDYITKNKVEFLYSNTDKKQEIKMVFDNWEIINGGSSNF
LRIKTPIKEGYFKVKNTTIDLSGVNPVLEIKLDFFNDISDPNIKKLKFNFGSESNDDIKI
IVSDLNGKLQEEDEFYFNKLLINAFIQNEKQISYIFASLNVTSDIEWMNPKQFKFVYYSP
TDNSDGYLFILSVVTNRDISELSVNVDGNILGNNSEVGLLISEKLFLKNLVLPKLSSNMG
SDITSNNFKVISTSDTTGRIANNSTLNWYGIKVGLIWYYPKINNFSMELFEGNKLKTKLS
GIVRLTGYERIYSELNLECTTKFIYDPKNKKTSFEYYKTSIMSCRPIFGLLDGVPALVAK
SVGDWSLKSFRNSLAFGLTNNFTDIINGIVRWNNLKISEVTNVTLNVGFCIQGNAN*
>PROKKA_00005 Tetanus toxin precursor
MKINNNFNIDSPVDNKDVAIVRGRKTDIFLKVFQVAPNIWVAPERYYGESLNINEDQKSD
GGIYDSNFLLTNDEKDEFLQATVKILQRINNNVIGAKLLSLISTAIPFPYEYKPGDYRQT
NYLVSKDNQHYYTANLVIFGPGTNIVENNAVYYKKEDSENGMGTMSEIWFQPFLTYKYDQ
FYVDPALELIKCLIKSLYYLYGIKPSDDLSIPYRLRSELNSLKYSELDMVDFLISGGTDY
KLLNTNPYWVTDNYFSDAPKNFEKYKNDYETKIKNNNDIANSIKLYLEQKFKINAQDIWE
LNLSYLSTEFEIMMPEIFNNALNHYHRKEYYVIDYFKNYNINGFINGQIKTILPLSKYNK
NIINKPELIVNLINENNSVLMKSNVYGDGLKGTMNNFYAVYKIPYNIGDEYHINYSYLNN
VNVEEINNIPPINDADIYPYRKNSDPFIPVYNITETKEINTTTPLSVNYLQAQVTNSNDI
NLSLDFSKVISLKDRSLVYSFLDNTIDYLDSIKYDEPINTDKKYYLWLKEIFRNYSFDMT
EIQEVNIPCGINKVVPWLGKALNILNTGNSFIEEFKTLGPISLINKKENIIMPKIEIDEI
PNSMLNLSFKDLSENLFNIFSKNNSYFEKIYYDFLDQWWTQYYSQYFDLICMAKRSVLAQ
ESLIKKIIQKKLSYLIGNSNISADNLVLMNLTTTNTLRDISNESQIAMNNVDSFLNSAAI
CVFEGNIYPKFISFMEQCINNINKNTREFIQKCTNITENEKLQLINRNIFSSLDFDFLNI
ENLKSLFSSETALLIKEETSPYELVLYAFQEPDNNAIGDASAKNTSIEYSKDIDLVYGIN
GDALYLNGANQSISFSNDFFENGLTNSFSIYFWLRNLGKDTIKSKLIGSKEDNCGWEIYF
QDTGLVFNMIDSNGNEKNIYLSDVSNNSWHYITISIDRLKEQLLIFIDDNLVVNESIKEI
LNIYSSNIISLLSNNNASYIEGLTILNKPTTSQEVLSNYFKNLNNSYIRDSNEERLEYNK
TYQLYNYVFSENPIYEIKQNNNIYLTINNTNNLNLQASKFKLLSINPNKQHVQKFDEVII
SILDNMEKYIDISEDNRLQLIDNKNGAKKMIISNNIFISNCLTLSCGGKYICLSMKDENY
NWMICNNESNIPKKAYLWTLKEV*
>PROKKA_00006 Botulinum neurotoxin type F precursor
MPVVINSFNYNDPVNDDTILYMQIPYEEKSKKYYKAFEIMRNVWIIPERNTIGTDPSDFD
PPASLENGSSAYYDPNYLTTDAEKDRYLKTTIKLFKRINSNPAGEVLLQEISYAKPYLGN
EHTPINEFHPVTRTTSVNIKSSTNVKSSIILNLLVLGAGPDIFENSSYPVRKLMDSGGVY
DPSNDGFGSINIVTFSPEYEYTFNDISGGYNSSTESFIADPAISLAHELIHALHGLYGAR
GVTYKETIKVKQAPLMIAEKPIRLEEFLTFGGQDLNIITSAMKEKIYNNLLANYEKIATR
LSRVNSAPPEYDINEYKDYFQWKYGLDKNADGSYTVNENKFNEIYKKLYSFTEIDLANKF
KVKCRNTYFIKYGFLKVPNLLDDDIYTVSEGFNIGNLAVNNRGQNIKLNPKIIDSIPDKG
LVEKIVKFCKSVIPRKGTKAPPRLCIRVNNRELFFVASESSYNENDINTPKEIDDTTNLN
NNYRNNLDEVILDYNSETIPQISNQTLNTLVQDDSYVPRYDSNGTSEIEEHNVVDLNVFF
YLHAQKVPEGETNISLTSSIDTALSEESQVYTFFSSEFINTINKPVHAALFISWINQVIR
DFTTEATQKSTFDKIADISLVVPYVGLALNIGNEVQKENFKEAFELLGAGILLEFVPELL
IPTILVFTIKSFIGSSENKNKIIKAINNSLMERETKWKEIYSWIVSNWLTRINTQFNKRK
EQMYQALQNQVDAIKTVIEYKYNNYTSDERNRLESEYNINNIREELNKKVSLAMENIERF
ITESSIFYLMKLINEAKVSKLREYDEGVKEYLLDYISEHRSILGNSVQELNDLVTSTLNN
SIPFELSSYTNDKILILYFNKLYKKIKDNSILDMRYENNKFIDISGYGSNISINGDVYIY
STNRNQFGIYSSKPSEVNIAQNNDIIYNGRYQNFSISFWVRIPKYFNKVNLNNEYTIIDC
IRNNNSGWKISLNYNKIIWTLQDTAGNNQKLVFNYTQMISISDYINKWIFVTITNNRLGN
SRIYINGNLIDEKSISNLGDIHVSDNILFKIVGCNDTRYVGIRYFKVFDTELGKTEIETL
YSDEPDPSILKDFWGNYLLYNKRYYLLNLLRTDKSITQNSNFLNINQQRGVYQKPNIFSN
TRLYTGVEVIIRKNGSTDISNTDNFVRKNDLAYINVVDRDVEYRLYADISIAKPEKIIKL
IRTSNSNNSLGQIIVMDSIGNNCTMNFQNNNGGNIGLLGFHSNNLVASSWYYNNIRKNTS
SNGCFWSFISKEHGWQEN*
>PROKKA_00007 Autolytic lysozyme
MLKGIDASEHQGEIGWKAVKNSGIQFAILRAGYGKNNIDKQFINNANGCTGVGMPFGLYW
FSYAYTEDMARKEAQYCVTQAKKYKISYPICYDLEYDTIRYANNCGVTITKSLATKMVHA
FCQEVERNGYFAMNYSNQDFLLNKFDSNLLKRYALWYAWYNNSLNRKCGIWQYSENGRVP
GIAGAAVDMNYCYLNMPGASNTSPNKNTFRGGHYLIRELQQEINSQGLGEVVVDGIAGQA
TINSAPVCKQGARGGITKVIQQMLISIGYPVGSHGADGVFGDSTVTAIKAFQKDCHLVAD
GIVGKET*
>PROKKA_00008 hypothetical protein
MKTIRFKIVAGINEEYFHESENKNRIQIVGV*
>PROKKA_00009 Nucleoside 2-deoxyribosyltransferase
MSKRVFLAAPFKGTIKEKQSIMKEQEKKRIEDLILFLEEKGWKVDNAHKREEWGANFMSP
DQCTKLDYDAIKECDLFIAFPGVPVSPGTHIEIGWASAMGKEIILLLAEKEENYAYLIRG
LHTVSNVHYIIYNEEKEYLQKLDLYLDGENNEV*
>PROKKA_00010 Thymidylate synthase 2
MKFKNFHEAYLRNLNDVYYTPEFINQPRGNVSKERLNYFMILENPRERICYTKSRKTNIV
FNFAEALWYLSGSNDLDYISYYASNMKKYSMDGKILTGTAYGPKIFSYGHNNINQWHRII
ELFKEDPDTKRGFIEIFDANEDLSLKNIDVSCTIGFQFFIREHKLYMTTFMRANDAYRGI
ISDVFSFTFIQEFLATELNLDIGQYSHQVATTHIYEPDFKLAEKVLCESKSDKKELSFPR
MPKKDNWEDLKIVLQYEKELRKKSIHLTKKDIDELEIDKYWKQIICLFVLYQEIYYGDNL
DYEIYESLEPLYQYLFSNKWNQYF*
>PROKKA_00011 ubiquinone/menaquinone biosynthesis methyltransferase
MESIFLGGDILGTCWKDEEVSKKFNLYNDMLENILGFDYIFQNLKSNESIKKILDFGCGP
GKVAERMAKIKPESQIIAVDQSQNMLDIAMKEHNKENIDYRLIEQNQLKEIEKNSIDCVV
LCFVIINNSDKDRIKTIFQEIFRVLKKGGKFFILDSNPNAVGIEFSTFTNGKSGQAYHLG
DHKKQFLKIPNNEVLILEDYYWPIDFYINNLEAVGFENYKIVEPTIEKINKPDLNAIEKT
YDIKCWGSEKNKPPFIIFDVEK*
>PROKKA_00012 Thiaminase-1 precursor
MKLKNLFKRSLSLLFSFIMIFTLVSGLDVKAFSGDESKQTLNVALYEYVPDPVRFKKAVE
TEWNKKEPNIKLNFVDWDCYSEDPPKDLDVFVFDAIYLSHFVKEGYLSEIPEKDIKNKED
ILPFAMEGCTIKGSAYAIPQIICTNLLFSRKGDYDIQKVNSVYDLYDKLGKSTSEDIILP
NNKGLLIDMSGGTSKACMYLDSLIDTTQEYTKFCSLPNLNELNKDAIDSLILLQAMAGKS
QANYWPENNDSYIRAKWFINGKGRAYIGYTEAMSQMKEFANDIDFKTISLSKNSNIPIFY
GDVVGINSSITNSYKKEKAIELANIITDKNTMVKAVSPDENNEYPQYLLPARRNVYHNLE
NKYPIYGRLYKIADNPNNKLFRTGPEIREWLKQAKKIITEYLQQ*
>PROKKA_00013 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MKKVLSIAGSDCSGGAGIQADLKTFSAHGVFGMSVIVSVVAENTSRVIDIQDVTPDMIKS
QIDAVYEDIGTDAVKIGMLSTPDCMKAVSEKLQEYKPKNVVIDPVMYAKNGCPLMDPNSV
STLIESIIYHADILTPNIPEAERISGYKIKTLEDMEKAAGIIEGMGCKSVLIKGGHYIGD
AVDVLYDGNKFYHYKTQRIHTKNTHGTGCTLSSAIASNLALGFEINEAVKRAKNYITMAI
EHSLEIGKGNGPTNHFYQVYLNGLKGMELDNHTRS*
>PROKKA_00014 hypothetical protein
MRKVYKNPKELATCLKDLVDLYFEDIMTYEKLEEKVSKIVEANKDSIYKNGVINTKLANV
LGNLRIDVINKIVKEEN*
>PROKKA_00015 putative membrane protein
MTKYAIVFFMSMVPIIELRGAIPYSQMYNLPLLQSYIIAIIGNMLPMPFIYLFARKVLVW
GSDKPITGKFFTWCLEKGEKAGKKLQEKTGKKGLFWGLLIFVAIPAPGTGAWTGTLAASL
LDMDFKTSILAVMLGVLVAGIIMGTASVGLFSFF*
>PROKKA_00016 putative ABC transporter ATP-binding protein YxlF
MDKSNDVVVSIRNLKMSYGSKEVLKGINLDVNKGEIIGYIGPNGAGKSTTVKIILGLVKG
YEGEVKILGNNISYENVEYKHKIGYVPENGEIYDNLTAYEYITFLGEIYGMKLEDVNNKA
KKLMSLFGIEEAYHSRISSYSKGMRQKLLIISSLIHNPDILFLDEPLSGLDANSVLVFKE
VLSKLASEGKTIFYSSHIMEVVEKISSRIILLNNGQIAADGTFEELKKKNMEGSLEQIFN
QITGFTKHEEIANEFISVLKEV*
